The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,733.50
Bid: 1,732.50
Ask: 1,733.00
Change: 0.00 (0.00%)
Spread: 0.50 (0.029%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1,733.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET OPEN: Pharma Stocks Lead Gains; Sage Group Shares Down

Wed, 02nd Dec 2015 08:29

LONDON (Alliance News) - UK shares opened higher Wednesday morning, with pharmaceutical stocks leading the gainers, while shares in Sage Group were sold after the company reported lower pretax profit in its last financial year.

The FTSE 100 index opened up 0.4% at 6,423.58 points, the FTSE 250 was up 0.3% at 17,559.64 and the AIM All-Share was up 0.3% at 740.30. In Europe, the CAC 40 index in Paris was up 0.1%, while the DAX 30 in Frankfurt was flat.

Sage Group was down 2.8%, making it the worst performing stock in the blue-chip index, after it said its pretax profit edged lower in its recently-ended financial year due to restructuring costs, but its organic growth hit its target and the group remains confident on its outlook.

The enterprise software provider said its pretax profit for the year to the end of September was GBP275.8 million, slightly down from the GBP278.7 million it made a year earlier, due to higher one-off selling and administrative costs related to restructuring activity to save costs. Stripping out those one-offs, pretax profit rose to GBP358.5 million from GBP340.9 million.

Sage will pay a total dividend for the year of 13.10 pence per share, up from 12.12p the year before.

Drugmaker Astrazeneca was up 1.6% after being upgraded to Overweight from Underweight by Morgan Stanley. GlaxoSmithKline was also up 1.4% at 1,371p after the broker lifted the company's price target to 1,450p from 1,350p. Meanwhile, shares in Shire were adding 2.0%.

In the FTSE 250, Pub operator Greene King was the best mid-cap stock, up 6.8%, after it said its pretax profit and revenue rose in the first half thanks to the integration of the Spirit Pub business, though like-for-like sales growth also was solid and the group hiked its interim dividend.

Green King said its pretax profit for the 24 weeks to October 18 was GBP84.9 million, up from GBP72.0 million, as revenue surged up to GBP917.7 million from GBP614.9 million, driven by the acquisition of rival Spirit Pub Co. The group will pay an interim dividend of 8.45 pence, up from 7.95p.

At the other end of the mid-cap index, price comparison site Moneysupermarket.com Group was down 6.6% after saying its founder Simon Nixon has sold a 5.8% stake in the company through a share placing, almost half of his holding, and the company said he will step down from the board at the end of the year.

Nixon placed 32.0 million shares at 305.00 pence per share, raising gross proceeds of GBP98.0 million for Nixon. Shares in Moneysupermarket closed at 328.30p on Tuesday. The plan for the placing, conducted by Credit Suisse, had been disclosed on Tuesday.

Investors are likely to focus Wednesday on eurozone inflation data, due at 1000 GMT, a day before Thursday's highly anticipated European Central Bank monetary policy meeting.

Economists expect the inflation data to show a moderate pick-up year-on-year to 0.2% from a previous reading of 0.1% in October.

Oanda analyst Craig Erlam said the data could possibly still influence how aggressively the ECB will ease its monetary policy, "with any unexpected pickup in the data supporting a less bold approach."

The analyst said the market is expecting a cut to the deposit rate of between 10 and 20 basis points and an increase of between EUR10 billion and EUR20 billion in the bond buying program.

"A move at the lower end of this scale could disappoint investors, especially given the ECB's history of over-delivering once the decision to ease has been made," the analyst notes.

Also in the economic calendar, UK Construction PMI is expected at 0930 GMT. In the US, ADP employment change data are due at 1315 GMT, while Energy Information Administration crude oil stocks are due at 1530 GMT. At 1700 GMT, Federal Reserve Chair Janet Yellen speaks before the Economic Club of Washington, while at 1900 GMT, the Fed releases its Beige Book.

By Daniel Ruiz; danielruiz@alliancenews.com

Copyright 2015 Alliance News Limited. All Rights Reserved.

More News
2 May 2024 19:57

GSK knew about Zantac cancer risk, attorneys tell jury in first trial

May 2 (Reuters) - U.S. attorneys for a woman who claims her colon cancer was caused by the now discontinued heartburn drug Zantac on Thursday told a jury in Chicago that pharmaceutical companies GSK and Boehringer Ingelheim knew the product could cause cancer if it was not handled properly but failed to warn the public.

Read more
2 May 2024 09:48

LONDON BROKER RATINGS: Deutsche Bank likes TP ICAP but says sell CMC

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

Read more
1 May 2024 19:39

Bird flu testing shows more dairy products are safe, US FDA says

CHICAGO, May 1 (Reuters) - Preliminary results of tests on additional dairy products show that pasteurization inactivates the bird flu virus, the U.S. Food and Drug Administration said on Wednesday.

Read more
1 May 2024 17:31

UK's FTSE 100 slips ahead of Fed outcome, energy stocks weigh

FTSE 100 down 0.3%, FTSE 250 off 0.2%

*

Read more
1 May 2024 16:56

LONDON MARKET CLOSE: FTSE 100 down ahead of US interest rate decision

(Alliance News) - Stock prices in London closed mostly in the red on Wednesday, as investors eye the latest interest rate decision from the US Federal Reserve this evening.

Read more
1 May 2024 16:42

London close: Stocks fall ahead of US Fed decision

(Sharecast News) - London markets closed lower on Wednesday, as investors digested the latest UK manufacturing data and anticipated an impending policy announcement from the US Federal Reserve.

Read more
1 May 2024 11:55

LONDON MARKET MIDDAY: FTSE 100 treads water as Fed takes centre-stage

(Alliance News) - London's FTSE 100 traded off session highs heading into Wednesday afternoon, as some pre-Federal Reserve decision nerves kicked in.

Read more
1 May 2024 10:54

GSK raises profit outlook on strong vaccine, HIV drug sales

FY profit forecast raised to 8-10%

*

Read more
1 May 2024 08:57

LONDON MARKET OPEN: FTSE 100 shakes off New York slump before Fed

(Alliance News) - Stock prices in London opened mixed on Wednesday, with the FTSE 100 brushing off some pre-Federal Reserve decision trepidation to record an early rise, while the dollar climbed on the expectation that Jerome Powell will sound hawkish in his press conference later.

Read more
1 May 2024 08:50

TOP NEWS: GSK expects momentum to continue after strong first quarter

(Alliance News) - GSK PLC on Wednesday raised its annual earnings forecast, and said it expects sales growth at the top-end of guidance, after a "strong" start to the year.

Read more
1 May 2024 07:46

LONDON BRIEFING: GSK ups outlook; Next first-quarter beats forecast

(Alliance News) - Equities in London are called to open flat on Wednesday, ahead of the latest Federal Reserve interest rate decision, while a host of financial markets in mainland Europe and beyond are closed for public holidays.

Read more
1 May 2024 07:36

GSK lifts annual guidance on strong virus treatment sales

(Sharecast News) - UK pharmaceutical giant GSK lifted annual profits guidance on Wednesday, as it pinned its hopes on demand for its respiratory virus and shingles treatments.

Read more
30 Apr 2024 23:46

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 22:39

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 13:51

Sensodyne maker Haleon to shut UK factory with loss of 435 jobs

(Alliance News) - More than 400 jobs are to be axed at Sensodyne toothpaste and Advil painkillers firm Haleon PLC as the group revealed plans to shut its only manufacturing site in the UK.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.